What does Visgeneer Inc. do?

Visgeneer Inc. (4197.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 4197.TWO's market cap?

Visgeneer Inc. (4197.TWO) has a market capitalization of approximately $247.2 million, as of August 27, 2026, based on the most recent share price and shares outstanding.

Does 4197.TWO pay a dividend?

Yes — Visgeneer Inc. (4197.TWO) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

4197.TWO

Visgeneer Inc.

TWO·Biotechnology · Healthcare

NT$8.19NT$0.38−4.43%

Market capNT$247.18M·Market closed·Aug 27 3:39 AM UTC

Price Chart

NT$8.19−NT$0.38 (−4.43%)today

−34.48%CAGR −8.11%

Select date range

FromTo

Oct 24, 2013Aug 27, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

4197.TWO does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

FinancialsFinancials Tab

RevenueNT$170.72M

Net Income−NT$3.75M

Net Margin−2.2%

Operating Cash Flow−NT$14.82M

Capital ExpendituresNT$8.12M

Free Cash Flow−NT$22.93M

Return on Equity−2.0%

Return on Invested Capital−2.4%

Net DebtNT$57.00M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 4197.TWO and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 4197.TWO's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 4197.TWO and 80,000+ other tickers.

About Visgeneer Inc.

Visgeneer, Inc. engages in the provision of biotechnology service. It specializes in blood glucose testers, blood glucose test tablets, blood ketone testers, blood ketone test tablets, and and skin care products. The company was founded on November 15, 2005 and is headquartered in Hsinchu, Taiwan.

CEO: Kengshuo Dai
Sector: Healthcare
Industry: Biotechnology
Exchange: TWO
Employees: 98
Website: www.visgeneer.com

Peers

Peers Tab

6744.TWO

Feng Chi Biotech Corp.

Cap

NT$220.2M

6848.TWO

RBC Bioscience Corporation

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 4197.TWO

What does Visgeneer Inc. do?: Visgeneer Inc. (4197.TWO) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 4197.TWO's market cap?: Visgeneer Inc. (4197.TWO) has a market capitalization of approximately $247.2 million, as of August 27, 2026, based on the most recent share price and shares outstanding.
Does 4197.TWO pay a dividend?: Yes — Visgeneer Inc. (4197.TWO) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.